Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.
Gaillard V, Lhuillier A, Bigot C, Pierard L, Trensz P, Burgy M, Schuster C, Malouf G, Fritsch A, Lang H, Tricard T, Borchiellini D, Geoffrois L, Barthelemy P. Gaillard V, et al. Among authors: bigot c. Support Care Cancer. 2022 Aug;30(8):6583-6591. doi: 10.1007/s00520-022-07088-1. Epub 2022 Apr 29. Support Care Cancer. 2022. PMID: 35484315
Advanced nccRCC: what therapeutic options in 2022?
Bigot C, Boudier P, Ladoire S, Barthélémy P. Bigot C, et al. Bull Cancer. 2022 May;109(2S):2S39-2S46. doi: 10.1016/S0007-4551(22)00237-5. Bull Cancer. 2022. PMID: 35760469
A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer.
Bischoff H, Bigot C, Moinard-Butot F, Pflumio C, Fischbach C, Kalish M, Kurtz JE, Pierard L, Demarchi M, Karouby D, Coliat P, Pivot X, Petit T, Cox DG, Goepp L, Bender L, Trensz P. Bischoff H, et al. Among authors: bigot c. Breast Cancer Res Treat. 2023 Feb;198(1):23-29. doi: 10.1007/s10549-022-06844-5. Epub 2022 Dec 23. Breast Cancer Res Treat. 2023. PMID: 36562910
Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas.
Moinard-Butot F, Oriel M, Tricard T, Cazzato RL, Pierard L, Gaillard V, Werle P, Lindner V, Martin S, Schuster C, Roy C, Burgy M, Anthony A, Bigot C, Boudier P, Fritsch A, Olland A, Malouf G, Lang H, Barthélémy P. Moinard-Butot F, et al. Among authors: bigot c. Clin Genitourin Cancer. 2024 Oct;22(5):102134. doi: 10.1016/j.clgc.2024.102134. Epub 2024 Jun 5. Clin Genitourin Cancer. 2024. PMID: 38909529 Free article.
Inside Geitawi's burns unit.
Bigot C. Bigot C. Lancet. 2024 Oct 26;404(10463):1628-1629. doi: 10.1016/S0140-6736(24)02348-1. Lancet. 2024. PMID: 39492345 No abstract available.
Ezrin, radixin, and moesin are dispensable for macrophage migration and cellular cortex mechanics.
Verdys P, Rey Barroso J, Girel A, Vermeil J, Bergert M, Sanchez T, Métais A, Mangeat T, Bellard E, Bigot C, Astarie-Dequeker C, Labrousse A, Girard JP, Maridonneau-Parini I, Vérollet C, Lagarrigue F, Diz-Muñoz A, Heuvingh J, Piel M, du Roure O, Le Cabec V, Carréno S, Poincloux R. Verdys P, et al. Among authors: bigot c. EMBO J. 2024 Nov;43(21):4822-4845. doi: 10.1038/s44318-024-00173-7. Epub 2024 Jul 18. EMBO J. 2024. PMID: 39026000 Free PMC article.
Impact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19.
Le Terrier C, Walter T, Lebbah S, Hajage D, Sigaud F, Guérin C, Desmedt L, Primmaz S, Joussellin V, Della Badia C, Ricard JD, Pugin J, Terzi N; COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Le Terrier C, et al. Ann Intensive Care. 2024 Jun 27;14(1):100. doi: 10.1186/s13613-024-01340-z. Ann Intensive Care. 2024. PMID: 38935175 Free PMC article.
Ventilator-associated pneumonia related to extended-spectrum beta-lactamase producing Enterobacterales during severe acute respiratory syndrome coronavirus 2 infection: risk factors and prognosis.
Razazi K, Luyt CE, Voiriot G, Rouzé A, Garnier M, Ferré A, Camous L, Heming N, Lapidus N, Charles-Nelson A, Mekontso-Dessap A; COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Razazi K, et al. Crit Care. 2024 Apr 20;28(1):131. doi: 10.1186/s13054-024-04906-2. Crit Care. 2024. PMID: 38641851 Free PMC article.
58 results